Anti-ischemic effect of verapamil during an interventional recanalisation;Antiischamische wirkung von verapamil im rahmen einer interventionellen rekanalisation

Herz

Volumn 24, Issue 7, 1999, Pages 581-586

  Oldenburg, Olaf ^a   Baumgart, Dietrich ^b   Schaar, Johannes ^b   Eggebrecht, Holger ^b   Caspari, Guido ^b   Haude, Michael ^b   Erbel, Raimund ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NONE

Author keywords

Blood flow velocity; Coronary intervention; Coronary vasoconstriction; Verapamil; adrenergic mechanisms

Indexed keywords

GLYCERYL TRINITRATE; HEPARIN; LIDOCAINE; VERAPAMIL; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; BLOOD FLOW VELOCITY; CASE REPORT; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY STENT; ELECTROCARDIOGRAM; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; RECANALIZATION; REVIEW; UNSTABLE ANGINA PECTORIS; VASOCONSTRICTION; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY THROMBOSIS; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART MUSCLE ISCHEMIA; MIDDLE AGED; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD FLOW VELOCITY; CALCIUM CHANNEL BLOCKERS; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; CORONARY THROMBOSIS; ELECTROCARDIOGRAPHY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; VERAPAMIL;

EID: 0032759908     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03044230     Document Type: Review

References (18)

1. Baumgart D, Haude M, Görge G, et al. Augmented α-adrenergic constriction of atherosclerotic human coronary arteries. Circulation 1999;99:2090-7.
2. Bernstein EA, Eberli FR, Silverman AM, et al. Beneficial effects of felodipine on myocardial and coronary function during low - flow ischemia and reperfusion. Cardiovasc Drugs Ther 1996;10:167-78.
3. Braunwald E. Unstable angina. A classification. Circulation 1989;80:410-4.
4. Ge J, Baumgart D, Haude M, et al. Role of intravascular ultrasound imaging in identifying vulnerable plaques. Herz 1999;24:32-41.
5. Ge J, Simon HU, Jeremias A, et al. Angiographic coronary slow flow phenomenon indicates microvascular dysfunction: An intracoronary doppler study. Circulation 1997;96:Suppl I:273.abstract.
6. Gregorini L, Marco J, Kozakova M, et al. α-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation 1999;99:482-90.
7. Gregorini L, Fajadet J, Robert G, et al. Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents. Circulation 1994;90:895-907.
8. Haude M, Caspari G, Baumgart D, et al. Comparison of myocardial perfusion reserve before and after coronary ballon predilatation and after stent implantation in patients with postangioplasty restenosis. Circulation 1996;94:286-97.
9. Heusch G, Deussen A. Nifedipine prevents sympathetic vasoconstriction distal to severe coronary stenoses. J Cardiovasc Pharmacol 1984;6:378-83.
10. Jespersen CM. Anti-ischemic intervention as prognosis improvement in patients with coronary artery disease, with special focus on verapamil. Am J Cardiol 1996;77:32D-6D.
11. Kern MJ. Appreciating α-adrenergic receptors and their role in ischemic left ventricular dysfunction. Circulation 1999;99:468-71.
12. Kern MJ, Deligonul U, Vandormael M, et al. Impaired coronary vasodilator reserve in the immediate postcoronary angioplasty period: analysis of coronary artery flow velocity indexes and regional cardiac venous efflux. J Am Coll Cardiol 1989;13:860-72.
13. Mandinov L, Kaufmann P, Eberli E, et al. Enhanced coronary vasoconstriction after PTCA in patients with acute ischemia. Basic Res Cardiol 1998;93:Suppl 3:44-9.
14. Oldenburg O, Mende K, Brisse B, et al. Kalciumantagonisten vermindern die Cold Pressor Test induzierte paradoxe Vasokonstriktion koronararterieller Gefäße bei KHK-Patienten. Z Kardiol 1997;86:Suppl 3:20.abstract.
15. Oldenburg O, Mende K, Brisse B, et al. Koronare Gefäßreaktionen der LCA im Cold Pressor Test in verschiedenen Gefäßsegmenten bei KHK. Z Kardiol 1995;84:Suppl 1:178.abstract.
16. Rang HP, Dale MM, Ritter JM. Pharmacology, 4th edn. Edinburgh-London-New York-Philadelphia-Sydney-Toronto:Living-stone, 1999:13-6.
17. Rauch B, Richardt G, Barth R, et al. Intracoronary gallopamil during percutaneous transluminal coronary angioplasty. J Cardiovasc Pharmacol 1992;20:Suppl 7:S32-9.
18. Winniford MD, Willerson JT, Hillis LD. Calcium antagonists for acute ischemic heart disease. Am J Cardiol 1985;55:116B-24B.